DSGN · Categories · Form 4

DSGN - SEC Form 4 insider transactions

Design Therapeutics Inc. (DSGN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for DSGN

• 64d
  SEC Form 4 filed by Shapiro David

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 150d
  SEC Form 4 filed by Chief Medical Officer Storgard Chris

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 150d
  SEC Form 4 filed by Chief Operating Officer Jeffries Sean

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 150d
  SEC Form 4 filed by Chief Accounting Officer Burgess Julie

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 150d
  SEC Form 4 filed by Director Gover Justin D.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 150d
  SEC Form 4 filed by President, CEO and Chairperson Shah Pratik

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 175d
  SEC Form 4 filed by President, CEO and Chairperson Shah Pratik

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 267d
  SEC Form 4 filed by Director Gover Justin D.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 294d
  Director William Arsani sold $2,953,792 worth of shares (562,627 units at $5.25) (SEC Form 4)

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 357d
  SEC Form 4 filed by Director George Simeon

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 357d
  SEC Form 4 filed by Director William Arsani

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 357d
  SEC Form 4 filed by Director Prasad Deepa

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 357d
  SEC Form 4 filed by Director Berger Heather A.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 357d
  SEC Form 4 filed by Director Schmid John P.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 357d
  SEC Form 4 filed by Director Lappe Rodney W

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 377d
  SEC Form 4 filed by Chief Medical Officer Storgard Chris

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 513d
  SEC Form 4 filed by Director Lappe Rodney W

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 513d
  SEC Form 4 filed by President, CEO and Chairperson Shah Pratik

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 513d
  SEC Form 4 filed by Chief Operating Officer Jeffries Sean

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 513d
  SEC Form 4 filed by Chief Accounting Officer Burgess Julie

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 531d
  Director Prasad Deepa sold $23,864 worth of shares (3,806 units at $6.27), decreasing direct ownership by 16% to 20,000 units (SEC Form 4)

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 661d
  Director William Arsani sold $3,463,214 worth of shares (814,874 units at $4.25) (SEC Form 4)

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 717d
  SEC Form 4 filed by Director George Simeon

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 717d
  SEC Form 4 filed by Director Prasad Deepa

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 717d
  SEC Form 4 filed by Director Lappe Rodney W

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 717d
  SEC Form 4 filed by Director William Arsani

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 717d
  SEC Form 4 filed by Director Schmid John P.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 717d
  SEC Form 4 filed by Director Berger Heather A.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 881d
  SEC Form 4 filed by Burgess Julie

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 881d
  SEC Form 4 filed by Jeffries Sean

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 911d
  SEC Form 4 filed by Lappe Rodney W

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 911d
  SEC Form 4 filed by Ansari Aseem Z.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1002d
  SEC Form 4: William Arsani converted options into 2,032,501 shares and bought $14,000,000 worth of shares (700,000 units at $20.00) (Amendment)

  4/A - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1003d
  SEC Form 4 filed by Shah Pratik

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1009d
  SEC Form 4: Prasad Deepa bought $27,670 worth of shares (12,000 units at $2.31), increasing direct ownership by 102% to 23,806 units

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1009d
  SEC Form 4: William Arsani bought $5,373,650 worth of shares (2,235,000 units at $2.40)

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1098d
  SEC Form 4 filed by George Simeon

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1098d
  SEC Form 4 filed by Xu Stella

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1098d
  SEC Form 4 filed by Schmid John P.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1098d
  SEC Form 4 filed by Prasad Deepa

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1098d
  SEC Form 4 filed by William Arsani

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1098d
  SEC Form 4 filed by Berger Heather A.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1098d
  SEC Form 4 filed by Lappe Rodney W

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1217d
  SEC Form 4 filed by Burgess Julie

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1217d
  SEC Form 4 filed by Jeffries Sean

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1217d
  SEC Form 4 filed by Shah Pratik

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1217d
  SEC Form 4 filed by Siffert Joao Md

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1261d
  SEC Form 4: Siffert Joao Md bought $62,503 worth of shares (7,450 units at $8.39), increasing direct ownership by 6% to 132,619 units

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1261d
  SEC Form 4: George Simeon bought $7,574,078 worth of shares (900,000 units at $8.42)

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1261d
  SEC Form 4: Sr One Capital Fund I Aggregator Lp bought $7,574,078 worth of shares (900,000 units at $8.42)

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1270d
  SEC Form 4: Lappe Rodney W bought $119,426 worth of shares (15,000 units at $7.96), increasing direct ownership by 15% to 112,024 units

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1449d
  SEC Form 4 filed by Xu Stella

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1449d
  SEC Form 4 filed by Lappe Rodney W

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1449d
  SEC Form 4 filed by Schmid John P.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1449d
  SEC Form 4 filed by William Arsani

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1449d
  SEC Form 4 filed by George Simeon

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1449d
  SEC Form 4 filed by Prasad Deepa

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1449d
  SEC Form 4 filed by Berger Heather A.

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1534d
  SEC Form 4: William Arsani bought $474,680 worth of shares (25,000 units at $18.99)

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)
• 1534d
  SEC Form 4: Xu Stella sold $11,266,197 worth of shares (590,880 units at $19.07)

  4 - Design Therapeutics, Inc. (0001807120) (Issuer)

Other DSGN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends